Our Dermatology Online – Journal Information
published since 01/06/2010 years
quarterly
e-ISSN: 2081-9390 (until issue 3.2023)
e-ISSN: 2956-7904 (from issue 4.2023)
DOI: 10.7241/ourd
Previous data (website and shortcut)
General Information
About Our Dermatology Online
Editors and Publishers
Editorial Policies
Statement of Human and Animal Rights
About Our Dermatology Online
Our Dermatology Online (Our Dermatol Online) published continuously since 2010 year, and delivers peer-reviewed research and clinical content to physicians, educators, and the global medical community.
The Our Dermatology Online editorial team employs:
Policies and practices to ensure that authors disclose all relevant financial associations and that such associations in no way influence the content Our Dermatology Online publishes.
EDITORIAL OFFICE Editor-in-Chief Piotr Brzezinski, MD PhD
-Department of Dermatology, 6th Military Support Unit, Ustka, Poland
-Department of Dermatology, Provincial Specialist Hospital in Slupsk, Ustka, Poland
-Department of Physiotherapy and Medical Emergency, Faculty of Health Sciences, Pomeranian University, Slupsk, Poland
Associate Editor Vikash Paudel, MBBS, MD
-Department of Dermatology National Medical College Province 2, Nepal |
PUBLISHER Adress ODO Publishing House
ul. Orlat Lwowskich 2, 76-200 Slupsk,
Poland
tel. 48 692 121 516, fax. 48 59 815 18 29 https://odopublishing.com/
e-mail: odermatol@yahoo.com; e-mail: contact@odermatol.com
|
Open-access—freely accessible online, authors retain copyright
Fast publication times
Community-based dialogue on articles
Worldwide
Our Dermatology Online journal is published by Our Dermatology Online, a nonprofit organization.
Why Publish in Our Dermatology Online?
- We use an international Editorial Board of over 90 experts, and a list of their areas of expertise is available at: http://www.odermatol.com/editorial-board/.
- The selective peer review and editorial evaluation, with 44% acceptance rate for all manuscripts (for year 2022)
- Rejected papers are given the opportunity for a formal appeal.
- Time to first decision as rapid as 1 day or 10 days; with peer review about 30 days.
- Time from submission to acceptance up to 30 days; acceptance to publication as low as 90 days.
- 1,308,753 thousand visits to Our Dermatology Online – International authors (Asia, Europe, Africa, the Americas) (for 13.10.2023).
- Free access” All articles are freely available on the day of publication in Our Dermatology Online.
- No author fees: no submission, page, color, or publication charges.
Indexing and Archiving
Our Dermatology Online is indexed in INDEX COPERNICUS (100.00), EBSCO-Academic Search Complete, DOAJ (Directory of Open Acces Journals), Crossref, ProQuest, MEN – 20.00, Most Wiedzy, Geneva Foundation for Medical Education and Research (GFMER), International Committee of Medical Journal Editors (ICMJE), Bielefeld Academic Search Engine (BASE), NewJour, Open J-Gate, Google Scholar, e-journal, WorldCat, Academic Journals Database, Journal Rank full.text.com, WorldWideScience.org, enamics JournalSeek, Hinari, National Science Library, LibSearch, Sciencegate, Virtual Science Library (VSL), Wanfang Data, COnnecting REpositories (CORE), CAB Abstracts, Global Health, OAIster: The Open Access Initiative, OAJSE – Open Access Journals Search Engine, Scirus, Journal Indexed in Directory of Research Journals Indexing, Academia.edu, Eurasian Scientific Journal Index.
Open Access Our Dermatology Online applies the Creative Commons Attribution License (CCAL) to all works we publish. Under the CCAL, authors retain ownership of the copyright for their article, but authors allow anyone to download, reuse, reprint, modify, distribute, and/or copy articles in Our Dermatology Online.
The Our Dermatology Online criteria for publication are as follows: The study presents the results of primary scientific research. Results reported have not been published elsewhere. Statistics, and other analyses are described in sufficient detail. Conclusions are presented in an appropriate fashion and are supported by the data. The article is presented in an intelligible fashion and is written in standard English, Spanish (allowed are also other languages). The research meets all applicable standards for the ethics of experimentation and research integrity. Each submission is subjected to an in-house quality control check, which deals with issues such as competing interests; ethical requirements for studies involving human participants or animals; Submissions may be returned to authors for queries, and will not be seen by our Editorial Board or Peer Reviewers until they pass this quality control check.
Useful links:
Centers for Disease Control and Prevention
Comments are closed.